共 50 条
- [11] The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol classEICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY 2, PTS A AND B, 1997, 400 : 381 - 386Sofia, MJ论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAFloreancig, P论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABach, N论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABaker, SR论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USANelson, K论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USASawyer, JS论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABaldwin, R论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USACockerham, SL论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAFleisch, JH论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAFroelich, LL论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAJackson, WT论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAMarder, P论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USARoman, CR论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USASaussy, DL论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USASilbaugh, SA论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USASpaethe, SM论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAStengel, PW论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
- [12] PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 270 (01): : 228 - 235CLOZEL, M论文数: 0 引用数: 0 h-index: 0BREU, V论文数: 0 引用数: 0 h-index: 0GRAY, GA论文数: 0 引用数: 0 h-index: 0KALINA, B论文数: 0 引用数: 0 h-index: 0LOFFLER, BM论文数: 0 引用数: 0 h-index: 0BURRI, K论文数: 0 引用数: 0 h-index: 0CASSAL, JM论文数: 0 引用数: 0 h-index: 0HIRTH, G论文数: 0 引用数: 0 h-index: 0MULLER, M论文数: 0 引用数: 0 h-index: 0NEIDHART, W论文数: 0 引用数: 0 h-index: 0RAMUZ, H论文数: 0 引用数: 0 h-index: 0
- [13] THE DISCOVERY OF A NEW STRUCTURAL CLASS OF POTENT ORALLY ACTIVE LEUKOTRIENE-D4 ANTAGONISTSBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (09) : 1141 - 1146LABELLE, M论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8PRASIT, P论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8BELLEY, M论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8BLOUIN, M论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8CHAMPION, E论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8CHARETTE, L论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8DELUCA, JG论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8DUFRESNE, C论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8FRENETTE, R论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8GAUTHIER, JY论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8GRIMM, E论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8GROSSMAN, SJ论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8GUAY, D论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8HEROLD, EG论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8JONES, TR论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8LAU, CK论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8LEBLANC, Y论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8LEGER, S论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8LORD, A论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8MCAULIFFE, M论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8MCFARLANE, C论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8MASSON, P论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8METTERS, KM论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8OUIMET, N论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8PATRICK, DH论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8PERRIER, H论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8PICKETT, CB论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8PIECHUTA, H论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8ROY, P论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8WILLIAMS, H论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8WANG, Z论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8XIANG, YB论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8ZAMBONI, RJ论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8FORDHUTCHINSON, AW论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8YOUNG, RN论文数: 0 引用数: 0 h-index: 0机构: Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Que. H9R 4P8
- [14] DISCOVERY OF MK-0476, A POTENT AND ORALLY-ACTIVE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST DEVOID OF PEROXISOMAL ENZYME-INDUCTIONBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (03) : 283 - 288LABELLE, M论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PABELLEY, M论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAGAREAU, Y论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAGAUTHIER, JY论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAGUAY, D论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAGORDON, R论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAGROSSMAN, SG论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAJONES, TR论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PALEBLANC, Y论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAMCAULIFFE, M论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAMCFARLANE, C论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAMASSON, P论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAMETTERS, KM论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAOUIMET, N论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAPATRICK, DH论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAPIECHUTA, H论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAROCHETTE, C论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PASAWYER, N论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAXIANG, YB论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAPICKETT, CB论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAFORDHUTCHINSON, AW论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAZAMBONI, RJ论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PAYOUNG, RN论文数: 0 引用数: 0 h-index: 0机构: MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA MERCK & CO INC,DEPT SAFETY ASSESSMENT,W POINT,PA
- [15] RS-39604 - A POTENT, SELECTIVE AND ORALLY-ACTIVE 5-HT4 RECEPTOR ANTAGONISTBRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) : 1087 - 1095HEGDE, SS论文数: 0 引用数: 0 h-index: 0机构: SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304 SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304BONHAUS, DW论文数: 0 引用数: 0 h-index: 0机构: SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304 SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304JOHNSON, LG论文数: 0 引用数: 0 h-index: 0机构: SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304 SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304LEUNG, E论文数: 0 引用数: 0 h-index: 0机构: SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304 SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304CLARK, RD论文数: 0 引用数: 0 h-index: 0机构: SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304 SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304EGLEN, RM论文数: 0 引用数: 0 h-index: 0机构: SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304 SYNTEX DISCOVERY RES,INST ORGAN CHEM,PALO ALTO,CA 94304
- [16] AQUARETIC EFFECT OF A POTENT, ORALLY-ACTIVE, NONPEPTIDE V-2 ANTAGONIST IN MENJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 272 (02): : 546 - 551OHNISHI, A论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANORITA, Y论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANTAKAGI, N论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANFUJITA, T论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANTOYOKI, T论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANIHARA, Y论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANYAMAMURA, Y论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANINOUE, T论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPANTANAKA, T论文数: 0 引用数: 0 h-index: 0机构: OSAKA UNIV,FAC MED,SCH ALLIED HLTH SCI,DEPT CLIN LAB SCI,OSAKA 506,JAPAN
- [17] DISCOVERY OF A-85783, A POTENT, ORALLY-ACTIVE ANTAGONIST OF PLATELET-ACTIVATING-FACTORABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 176 - MEDIHOLMS, JH论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064DAVIDSEN, SK论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064SHEPPARD, GS论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064CURTIN, ML论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064CARRERA, GM论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064HEYMAN, HR论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064PIREH, D论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064ALBERT, DH论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064CONWAY, RG论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064MAGOC, TJ论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064RHEIN, DA论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064TAPANG, P论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064SUMMERS, JB论文数: 0 引用数: 0 h-index: 0机构: ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064 ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064
- [18] L-660,711, A POTENT SELECTIVE AND ORALLY ACTIVE ANTAGONIST OF LEUKOTRIENE-D4LEUKOTRIENES AND PROSTANOIDS IN HEALTH AND DISEASE, 1989, 3 : 62 - 66YOUNG, RN论文数: 0 引用数: 0 h-index: 0ZAMBONI, R论文数: 0 引用数: 0 h-index: 0BELLEY, M论文数: 0 引用数: 0 h-index: 0CHAMPION, E论文数: 0 引用数: 0 h-index: 0CHARETTE, L论文数: 0 引用数: 0 h-index: 0DEHAVEN, R论文数: 0 引用数: 0 h-index: 0FRENETTE, R论文数: 0 引用数: 0 h-index: 0FORDHUTCHINSON, AW论文数: 0 引用数: 0 h-index: 0GAUTHIER, JY论文数: 0 引用数: 0 h-index: 0JONES, TR论文数: 0 引用数: 0 h-index: 0LEGER, S论文数: 0 引用数: 0 h-index: 0MCFARLANE, CS论文数: 0 引用数: 0 h-index: 0MASSON, P论文数: 0 引用数: 0 h-index: 0PIECHUTA, H论文数: 0 引用数: 0 h-index: 0PONG, SS论文数: 0 引用数: 0 h-index: 0ROKACH, J论文数: 0 引用数: 0 h-index: 0WILLIAMS, H论文数: 0 引用数: 0 h-index: 0
- [19] PHARMACOLOGY OF LR-B/081, A NEW HIGHLY POTENT, SELECTIVE AND ORALLY-ACTIVE, NONPEPTIDE ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONISTBRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) : 1117 - 1124CIRILLO, R论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYRENZETTI, AR论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYCUCCHI, P论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYGUELFI, M论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYSALIMBENI, A论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYCALIARI, S论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYCASTELLUCCI, A论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYEVANGELISTA, S论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYSUBISSI, A论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALYGIACHETTI, A论文数: 0 引用数: 0 h-index: 0机构: LUSOFARMACO,DEPT PHARMACOL,MILAN,ITALY
- [20] MK 287 - A POTENT, SPECIFIC, AND ORALLY-ACTIVE RECEPTOR ANTAGONIST OF PLATELET-ACTIVATING-FACTORJOURNAL OF LIPID MEDIATORS, 1993, 7 (02): : 115 - 134HWANG, SB论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065LAM, MH论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065SZALKOWSKI, DM论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065MACINTYRE, DE论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065BACH, TJ论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065LUELL, S论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065MEUER, R论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065SAHOO, SP论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065ALBERTS, AW论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065CHABALA, JC论文数: 0 引用数: 0 h-index: 0机构: MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065 MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065